Literature DB >> 6349759

Prevention and reversal of altered myocardial function in diabetic rats by insulin treatment.

A G Tahiliani, R V Vadlamudi, J H McNeill.   

Abstract

Isolated perfused hearts from diabetic rats exhibit a decreased responsiveness to increasing work loads. However, the precise time point at which functional alterations occur is not clearly established. Previous observations in our laboratory have suggested that the alterations in myocardial function are not apparent at 30 days whereas they are clearly seen 100 days after streptozotocin-induced diabetes. We studied the cardiac function of 6-week diabetic rats using the isolated perfused heart preparation. The 6-week time period was found to be sufficient to cause depression of myocardial function in these animals. We also studied the effect of insulin treatment on myocardial performance of diabetic rats. Insulin treatment was initiated 3 days and 6 weeks after injection of streptozotocin (STZ). The treatment was continued for 6 and 4 weeks in the respective groups. Hearts from 6-week diabetic animals exhibited a depressed left ventricular developed pressure (LVDP) and positive and negative dP/dt at higher filling pressures when compared with 6-week control animals. However, the depression was not seen in the 6-week insulin-treated diabetic animals. Ten-week diabetic rat hearts also showed a depression of LVDP and positive and negative dP/dt when compared with 10-week controls. The group of animals that had been diabetic for 6 weeks and then treated for 4 weeks with insulin exhibited a reversal of the depressed myocardial function. These results demonstrate that depression of myocardial performance, which is evident 6 weeks after diabetes is induced, can be prevented if insulin treatment is initiated as the disease is induced. Further, insulin treatment is capable of reversing the abnormalities after they have occurred.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6349759     DOI: 10.1139/y83-079

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  Sodium selenate corrects glucose tolerance and heart function in STZ diabetic rats.

Authors:  M L Battell; H L Delgatty; J H McNeill
Journal:  Mol Cell Biochem       Date:  1998-02       Impact factor: 3.396

2.  Astragalus prevents diabetic rats from developing cardiomyopathy by downregulating angiotensin II type2 receptors' expression.

Authors:  Changyun Li; Linsheng Cao; Qiutang Zeng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

3.  Pharmacological evaluation of "Glyoherb": A polyherbal formulation on streptozotocin-induced diabetic rats.

Authors:  Nima V Thakkar; Jagruti A Patel
Journal:  Int J Diabetes Dev Ctries       Date:  2010-01

4.  Attenuation of ischemia-reperfusion induced changes in cardiac performance and sarcoplasmic reticulum function by vanadate.

Authors:  Satoshi Takeda; Dashang Prajapati; Seibu Mochizuki; Vijayan Elimban; Naranjan S Dhalla
Journal:  Exp Clin Cardiol       Date:  2003

5.  Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts.

Authors:  Keshore R Bidasee; Karuna Nallani; Bruce Henry; U Deniz Dincer; Henry R Besch
Journal:  Mol Cell Biochem       Date:  2003-07       Impact factor: 3.396

6.  Cardioprotective effects of gallic acid in diabetes-induced myocardial dysfunction in rats.

Authors:  Snehal S Patel; Ramesh K Goyal
Journal:  Pharmacognosy Res       Date:  2011-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.